From outcomes research to disease management: A guide for the perplexed

Annals of Internal Medicine

Volumn 124, Issue 9, 1996, Pages 832-837

  Epstein, Robert S ^a,b   Sherwood, Louis M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Merck Medco Managed Care Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH CARE MANAGEMENT; INFORMATION SYSTEM; MEDICAL PRACTICE; MEDICAL RESEARCH; PHARMACOECONOMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY CONTROL; REVIEW; TREATMENT OUTCOME;

EID: 0029993603     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-9-199605010-00008     Document Type: Review

References (39)

1. Maimonides MB. Guide for the Perplexed Friedlander M, trans 2d ed London. Rautledge & Sons; 1904.
2. Rogers WJ, Johnstone DE, Yusuf S, Weiner DH, Gallagher P, Bittner VA, et al. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril the Studies of Left Ventricular Dysfunction The SOLVD Investigators. J Am Coll Cardiol. 1994;23:393-400
3. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet. 1994;344. 1383-9
4. Eaker E, Hahn RA. Women's health initiative [Letter]. N Engl J Med 1994, 330.70-1.
5. Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, et al. The effects of antihypertensive therapy on the quality of life N Engl J Med 1986;314 1657-64.
6. Roper WL, Winkenwerder W, Hackbarth GM, Krakauer H. Effectiveness in health care An initiative to evaluate and improve medical practice N Engl J Med 1988,319:1197-202.
7. Krakauer H, Bailey RC. Epidemiological oversight of the medical care provided to Medicare beneficiaries Stat Med 1991,10 521-40.
8. Maklan CW, Greene R, Cummings MA. Methodological challenges and innovations in patient outcomes research. Med Care. 1994,32.JS13-21.
9. Corrigan JM, Nielsen DM. Toward the development of uniform reporting standards tor managed care organizations. the Health Plan Employer Data and Information Set (Version 2 O) Jt Comm J Qual Improv. 1993;19:566-75
10. Donabedian A. Evaluating the quality of medical care Milbank Mem Fund Q. 1966,44 166-206
11. Donabedian A. The quality of medical care Science 1978,200.856-64
12. Donabedian A. Explorations in Quality Assessment and Monitoring 1 The Definition of Quality and Approaches to its Assessment. Ann Arbor, Ml Health Administration Pr; 1980 1-31.
13. Anderson GM, Spitzer WO, Weinstein MC, Wang E, Blackburn JL, Bergman U. Benefits, risks, and costs of prescription drugs: a scientific basis for evaluating policy options. Clin Pharmacol Ther 1990,48:111-9
14. Jones PW. Quality of life, symptoms and pulmonary function in asthmalong-term treatment with nedocromil sodium examined in a controlled multicentre trial Nedocromil Sodium Quality of Life Study Group. Eur Respir J 1994,7:55-62
15. Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma J Clin Epidemiol. 1992;45:461-72.
16. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma development of a questionnaire for use in clinical trials Thorax 1992,47 76-83
17. Hyland ME. The Living with Asthma Questionnaire Respir Med. 1991, 85(Suppl B) 33-7
18. Kirshner B, Guyatt G. A methodological framework for assessing health indices J Chronic Dis. 1985,38:27-36.
19. Revicki DA, Rothman M, Luce B. Health-related quality of life assessment and the pharmaceutical industry Pharmacoeconomics. 1992;1:394-408
20. Jaeschke R, Singer J, Guyatt GH. Measurement of health status Ascertaining the minimal clinically important difference. Controlled Clin Trials. 1989,10 407-15
21. Lydick E, Epstein RS. Interpretation of quality of life changes Qual Life Res 1993,2 221-6
22. Cleeland CS. Assessment of pain in cancer measurement issues Advances in Pain Research Therapy 1990;16 47-55
23. Guess HA, Jacobsen SJ, Girman CJ, Oesterling JE, Chute CG, Panser LA, et al. The role of community-based longitudinal studies in evaluating treatment effects- Example benign prostatic hyperplasia Med Care. 1996, 33(4 Suppl) AS26-35
24. Deyo RA, Patrick DL. The significance of treatment effects the clinical perspective. Med Care 1995,33(4 Suppl) AS286-91.
25. Brook RH, Ware JE Jr, Rogers WH, Keeler EB, Davies AR, Donald CA, et al. Does free care improve adults' health? Results from a randomized controlled trial N Engl J Med. 1983,309.1426-34
26. Brook RH, Lohr KN. Efficacy, effectiveness, variations, and quality Boundary-crossing research Med Care 1985,23.710-22
27. Perfetto EM, Epstein RS. Assessing patient outcomes of drug therapy, the role of pharmacoepidemiology. In: Hartzeman AG, Porta MS, Tilson HH, eds Pharmacoepidemiology An Introduction 3d ed Cincinnati Harvey Whitney Books, [In press].
28. Diamond GA, Denton TA. Alternative perspectives on the biased foundations of medical technology assessment. Ann intern Med 1993,118:455-64.
29. Oster G, Borok GM, Menzin J, Heyse JF, Epstein RS, Quinn V, et al. A randomized trial to assess effectiveness and cost in clinical practice rationale and design of the Cholesterol Reduction Intervention Study (CRIS) Control Clin Trials. 1995,16:3-16.
30. Oster G, Borok GM, Menzin J, Heyse JF, Epstein RS, Quinn V, et al. Cholesterol Reduction Intervention Study (CRIS) a randomized trial to assess effectiveness and costs in clinical practice Arch Intern Med. [In press]
31. Simon G, Wagner E, Vonkorff M. Cost-effectiveness comparisons using real world randomized trials the case of new antidepressant drugs J Clin Epidemiol 1995,48.363-73
32. Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, et al. Five-hundred life-saving interventions and their cost-effectiveness Risk Anal 1995;15 369-89
33. Ellwood PM. Shattuck lecture-outcomes management A technology of patient experiences. N Engl J Med. 1988,318:1549-56.
34. Steinwachs DM, Wu AW, Skinner EA. How will outcomes management work? Health Aff (Millwood). 1994;13.153-62.
35. Oxman AD, Sackett DL, Guyatt GH. Users' guides to the medical literature I How to get started The Evidence-Based Medicine Working Group JAMA. 1993,270 2093-5.
36. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature II How to use an article about therapy or prevention. A Are the results of the study valid? Evidence-Based Medicine Working Group JAMA 1993,270 2598-601
37. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature. II How to use an article about therapy or prevention B What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 1994,271:59-63
38. Tanke ED, Leirer VO. Automated telephone reminders in tuberculosis care. Med Care 1994,30 380-9.
39. Soghikian K, Casper SM, Fireman BH, Hunkeler EM, Hurley LB, Tekawa IS, et al. Home blood pressure monitoring Effect on use of medical services and medical care costs Med Care 1992,30 855-65.